Virios Therapeutics Says Phase 2b Study Of IMC-1 In Fibromyalgia Fails To Meet Primary Endpoint
(RTTNews) - Virios Therapeutics, Inc. (VIRI), a development-stage biotechnology company focused on chronic diseases, including fibromyalgia or FM,...
Michael Gendreau More Such Health News Virios Therapeutics Inc Herpes Simplex Chief Medical Officer Virios Therapeutics
Source: businessinsider.com